Data

HiWalk - A Phase II randomised trial of a mobility booster program after stroke

Macquarie University
Kate Scrivener (Aggregated by)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.25949/30782543.v1&rft.title=HiWalk - A Phase II randomised trial of a mobility booster program after stroke&rft.identifier=10.25949/30782543.v1&rft.publisher=Macquarie University&rft.description=This dataset reports outcomes from HiWalk, a multisite, assessor-blinded phase II pilot trial in Australia (June 2023–July 2024). The trial tested feasibility and effects of a short-duration, high-dose walking booster program (43 hours over 3 weeks) versus usual care for chronic stroke survivors living in the community who could walk unaided. Forty-seven participants (mean age 58, 2.7 years post-stroke) were randomised. The program aimed to improve mobility through high dose group-based motor training. The trial demonstrated strong feasibility in recruitment, retention, adherence, safety, and measurement. HiWalk improved self-efficacy at one month but showed no significant overall effect on walking speed.Please note: not all participants consented to data sharing and therefore an incomplete data set.&rft.creator=Kate Scrivener&rft.date=2026&rft_rights= https://creativecommons.org/licenses/by-nc-nd/4.0/&rft_subject=Rehabilitation&rft_subject=Physiotherapy&rft_subject=Allied health and rehabilitation science not elsewhere classified&rft_subject=Stroke&rft_subject=Walking&rft_subject=Mobility&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Licence & Rights:

Other view details

Full description

This dataset reports outcomes from HiWalk, a multisite, assessor-blinded phase II pilot trial in Australia (June 2023–July 2024). The trial tested feasibility and effects of a short-duration, high-dose walking booster program (43 hours over 3 weeks) versus usual care for chronic stroke survivors living in the community who could walk unaided. Forty-seven participants (mean age 58, 2.7 years post-stroke) were randomised. The program aimed to improve mobility through high dose group-based motor training. The trial demonstrated strong feasibility in recruitment, retention, adherence, safety, and measurement. HiWalk improved self-efficacy at one month but showed no significant overall effect on walking speed.

Please note: not all participants consented to data sharing and therefore an incomplete data set.

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related People

Related Grants and Projects

Related Websites

Subjects
Allied health and rehabilitation science not elsewhere classified | Mobility | Physiotherapy | Rehabilitation | Stroke | Walking |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information

url : https://researchers.mq.edu.au/en/projects/73954f74-27f7-4152-9a03-ba83e614e64c

Identifiers
ACN 633 798 857